Tech Company Financing Transactions

BioScale Funding Round

BioScale closed a $25 million funding round on 6/11/2010. Investors included Morningside Group, F2 Ventures and New Science Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Fortune Dr.
Lexington, MA 01821
USA

Phone

781.430.6800

Website

www.bioscale.com

Email Address

[email protected]

Overview

Bioscale develops a protein measurement technology that accelerates the discovery and development of biological and pharmaceutical products.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Scientific Officer

Martin Latterich

        

Chief Technical Officer

Brett Masters

        

Co-Founder

Mark Lundstrom

        

VP - Product Management

Michael Miller

        

Browse more venture capital transactions:

Prev: 6/11/2010: Castlight Health venture capital transaction
Next: 6/11/2010: Inotek Pharmaceuticals venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary